Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Near term impact on price

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Oct 03, 2022 10:56am

160 Views

Post# 35001499

RE:RE:Near term impact on price

Infinity wrote: DJ, I am so sure that we are negotiating from a position of weakness or out of desperation for cash flow. I am not agains the current PP. I wish the timing for the second PP had been phased out ove a 6 month time line. Ideally, after announcing the BTD application at a much higher price for both the shares and the warrants.

Sometime it's difficult to believe that they want to get SP at the higher price possible.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing